Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and …
ES Stroes, PD Thompson, A Corsini… - European heart …, 2015 - academic.oup.com
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-
adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This …
adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This …
Optimizing cholesterol treatment in patients with muscle complaints
RS Rosenson, S Baker, M Banach, KM Borow… - Journal of the American …, 2017 - jacc.org
Statins are highly effective for preventing cardiovascular events by reducing low-density
lipoprotein cholesterol (LDL-C). However, many patients taking statins report muscle-related …
lipoprotein cholesterol (LDL-C). However, many patients taking statins report muscle-related …
Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial
SE Nissen, E Stroes, RE Dent-Acosta, RS Rosenson… - Jama, 2016 - jamanetwork.com
Importance Muscle-related statin intolerance is reported by 5% to 20% of patients. Objective
To identify patients with muscle symptoms confirmed by statin rechallenge and compare …
To identify patients with muscle symptoms confirmed by statin rechallenge and compare …
Acid-suppressive medication use and the risk for hospital-acquired pneumonia
Context The use of acid-suppressive medication has been steadily increasing, particularly in
the inpatient setting, despite lack of an accepted indication in the majority of these patients …
the inpatient setting, despite lack of an accepted indication in the majority of these patients …
Narrative review: statin-related myopathy
TR Joy, RA Hegele - Annals of internal medicine, 2009 - acpjournals.org
Statin-related myopathy is a clinically important cause of statin intolerance and
discontinuation. The spectrum of statin-related myopathy ranges from common but clinically …
discontinuation. The spectrum of statin-related myopathy ranges from common but clinically …
Statin-induced myopathy: a review and update
TT Abd, TA Jacobson - Expert opinion on drug safety, 2011 - Taylor & Francis
Introduction: Statin-induced myopathy is an important cause of statin intolerance and the
most common cause of statin discontinuation. Observational studies estimate that 10–15 …
most common cause of statin discontinuation. Observational studies estimate that 10–15 …
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial
DJ Becker, RY Gordon, SC Halbert… - Annals of internal …, 2009 - acpjournals.org
Background: Red yeast rice is an herbal supplement that decreases low-density lipoprotein
(LDL) cholesterol level. Objective: To evaluate the effectiveness and tolerability of red yeast …
(LDL) cholesterol level. Objective: To evaluate the effectiveness and tolerability of red yeast …
[PDF][PDF] Statin myopathy: a common dilemma not reflected in clinical trials
G Fernandez, ES Spatz, C Jablecki… - … Clinic journal of …, 2011 - cdn.mdedge.com
Although statins are remarkably effective, they are still underprescribed because of concerns
about muscle toxicity. We review the aspects of statin myopathy that are important to the …
about muscle toxicity. We review the aspects of statin myopathy that are important to the …
[HTML][HTML] Intolerance to statins: mechanisms and management
R Bitzur, H Cohen, Y Kamari, D Harats - Diabetes care, 2013 - ncbi.nlm.nih.gov
Statins are considered very effective in reducing cardiovascular morbidity and mortality in
high-risk patients. However, although adherence to statins improves morbidity and mortality …
high-risk patients. However, although adherence to statins improves morbidity and mortality …
[HTML][HTML] Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
PD Thompson, J Rubino, MJ Janik… - Journal of clinical …, 2015 - Elsevier
Background Once-daily, oral ETC-1002 reduces low-density lipoprotein cholesterol (LDL-C)
and has beneficial effects on other cardiometabolic risk factors but has not been examined …
and has beneficial effects on other cardiometabolic risk factors but has not been examined …